ATE513819T1 - Neue n-(fluorpyrazinyl)phenylsulfonamide als modulatoren des chemokinrezeptors ccr4 - Google Patents
Neue n-(fluorpyrazinyl)phenylsulfonamide als modulatoren des chemokinrezeptors ccr4Info
- Publication number
- ATE513819T1 ATE513819T1 AT06835834T AT06835834T ATE513819T1 AT E513819 T1 ATE513819 T1 AT E513819T1 AT 06835834 T AT06835834 T AT 06835834T AT 06835834 T AT06835834 T AT 06835834T AT E513819 T1 ATE513819 T1 AT E513819T1
- Authority
- AT
- Austria
- Prior art keywords
- fluoropyrazinyl
- phenylsulfonamides
- modulators
- new
- chemokine receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
- C07D241/22—Benzenesulfonamido pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0502733 | 2005-12-12 | ||
PCT/SE2006/001409 WO2007069978A1 (en) | 2005-12-12 | 2006-12-11 | Novel n-(fluoro-pyrazinyl)-phenylsulfonamid.es as moodulators of chemokine receptor ccr4. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE513819T1 true ATE513819T1 (de) | 2011-07-15 |
Family
ID=38163190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06835834T ATE513819T1 (de) | 2005-12-12 | 2006-12-11 | Neue n-(fluorpyrazinyl)phenylsulfonamide als modulatoren des chemokinrezeptors ccr4 |
Country Status (21)
Country | Link |
---|---|
US (2) | US20080293742A1 (de) |
EP (1) | EP1968951B1 (de) |
JP (1) | JP2009519332A (de) |
KR (1) | KR20080091139A (de) |
CN (1) | CN101370793B (de) |
AR (1) | AR058319A1 (de) |
AT (1) | ATE513819T1 (de) |
AU (1) | AU2006325573A1 (de) |
BR (1) | BRPI0619602A2 (de) |
CA (1) | CA2631342A1 (de) |
CL (1) | CL2006003449A1 (de) |
EC (1) | ECSP088603A (de) |
ES (1) | ES2366807T3 (de) |
HK (1) | HK1121760A1 (de) |
IL (1) | IL191761A0 (de) |
NO (1) | NO20083070L (de) |
RU (1) | RU2008122401A (de) |
TW (1) | TW200730512A (de) |
UY (1) | UY29999A1 (de) |
WO (1) | WO2007069978A1 (de) |
ZA (1) | ZA200804921B (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI328007B (en) * | 2002-01-16 | 2010-08-01 | Astrazeneca Ab | Novel compounds |
ES2474615T3 (es) * | 2009-04-22 | 2014-07-09 | Axikin Pharmaceuticals, Inc. | Antagonistas de CCR3 arilsulfonamidas 2,5-disustituidas |
ES2939606T3 (es) * | 2013-09-02 | 2023-04-25 | Univ Melbourne | Un método de tratamiento |
CN104447756A (zh) * | 2014-11-10 | 2015-03-25 | 常州大学 | 一种五氟磺草胺中间体的制备方法 |
CN104402890A (zh) * | 2014-11-10 | 2015-03-11 | 常州大学 | 一种制备五氟磺草胺的方法 |
AU2018360766A1 (en) | 2017-11-06 | 2020-05-21 | Rapt Therapeutics, Inc. | Anticancer agents |
CN110028501B (zh) | 2018-01-12 | 2022-02-22 | 迈德欣国际有限公司 | 化合物及其制备方法和用途 |
CN108929279A (zh) * | 2018-07-27 | 2018-12-04 | 同济大学 | 一种含氟氨基吡嗪类化合物及其制备方法与应用 |
CN113893220A (zh) * | 2020-07-07 | 2022-01-07 | 迈德欣国际有限公司 | 鼻粘膜给药剂型和其应用 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB928151A (en) * | 1959-07-14 | 1963-06-06 | Farmaceutici Italia | Pyrazine derivatives |
US5962490A (en) * | 1987-09-25 | 1999-10-05 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
CZ291386B6 (cs) | 1996-02-13 | 2003-02-12 | Zeneca Limited | Chinazolinové deriváty jako inhibitory VEGF, způsob jejich přípravy a farmaceutický prostředek, který je obsahuje |
ES2169355T3 (es) | 1996-03-05 | 2002-07-01 | Astrazeneca Ab | Derivados de 4-anilinoquinazolina. |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
US6638937B2 (en) * | 1998-07-06 | 2003-10-28 | Bristol-Myers Squibb Co. | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
EP1289952A1 (de) | 2000-05-31 | 2003-03-12 | AstraZeneca AB | Indolderivate mit gefässschädigender aktivität |
EP1301497A1 (de) | 2000-07-07 | 2003-04-16 | Angiogene Pharmaceuticals Limited | Colchinol-derivate als gefässschädigende agenten |
CA2410562A1 (en) | 2000-07-07 | 2002-01-31 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as angiogenesis inhibitors |
SE0102439D0 (sv) * | 2001-07-05 | 2001-07-05 | Astrazeneca Ab | New compounds |
AU2002358390A1 (en) | 2001-12-18 | 2003-06-30 | Astrazeneca Ab | Novel compounds |
TWI328007B (en) * | 2002-01-16 | 2010-08-01 | Astrazeneca Ab | Novel compounds |
SE0301650D0 (sv) * | 2003-06-04 | 2003-06-04 | Astrazeneca Ab | Novel compounds |
SE0301654D0 (sv) * | 2003-06-05 | 2003-06-05 | Astrazeneca Ab | Novel compounds |
SE0301653D0 (sv) * | 2003-06-05 | 2003-06-05 | Astrazeneca Ab | Novel compounds |
SE0302304D0 (sv) * | 2003-08-27 | 2003-08-27 | Astrazeneca Ab | Novel compounds |
-
2006
- 2006-11-29 TW TW095144144A patent/TW200730512A/zh unknown
- 2006-12-11 BR BRPI0619602-0A patent/BRPI0619602A2/pt not_active Application Discontinuation
- 2006-12-11 JP JP2008545537A patent/JP2009519332A/ja active Pending
- 2006-12-11 WO PCT/SE2006/001409 patent/WO2007069978A1/en active Application Filing
- 2006-12-11 UY UY29999A patent/UY29999A1/es not_active Application Discontinuation
- 2006-12-11 CN CN2006800527066A patent/CN101370793B/zh not_active Expired - Fee Related
- 2006-12-11 ES ES06835834T patent/ES2366807T3/es active Active
- 2006-12-11 CL CL200603449A patent/CL2006003449A1/es unknown
- 2006-12-11 AT AT06835834T patent/ATE513819T1/de not_active IP Right Cessation
- 2006-12-11 US US12/096,513 patent/US20080293742A1/en not_active Abandoned
- 2006-12-11 AU AU2006325573A patent/AU2006325573A1/en not_active Abandoned
- 2006-12-11 KR KR1020087016880A patent/KR20080091139A/ko not_active Application Discontinuation
- 2006-12-11 EP EP06835834A patent/EP1968951B1/de active Active
- 2006-12-11 RU RU2008122401/04A patent/RU2008122401A/ru not_active Application Discontinuation
- 2006-12-11 CA CA002631342A patent/CA2631342A1/en not_active Abandoned
- 2006-12-12 AR ARP060105466A patent/AR058319A1/es unknown
-
2008
- 2008-05-27 IL IL191761A patent/IL191761A0/en unknown
- 2008-06-05 ZA ZA200804921A patent/ZA200804921B/xx unknown
- 2008-07-04 EC EC2008008603A patent/ECSP088603A/es unknown
- 2008-07-08 NO NO20083070A patent/NO20083070L/no not_active Application Discontinuation
-
2009
- 2009-02-24 HK HK09101721.5A patent/HK1121760A1/xx not_active IP Right Cessation
- 2009-12-08 US US12/633,548 patent/US20100144759A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20100144759A1 (en) | 2010-06-10 |
CN101370793B (zh) | 2012-01-04 |
ZA200804921B (en) | 2009-09-30 |
HK1121760A1 (en) | 2009-04-30 |
CN101370793A (zh) | 2009-02-18 |
JP2009519332A (ja) | 2009-05-14 |
CA2631342A1 (en) | 2007-06-21 |
IL191761A0 (en) | 2008-12-29 |
ES2366807T3 (es) | 2011-10-25 |
WO2007069978A1 (en) | 2007-06-21 |
AU2006325573A1 (en) | 2007-06-21 |
ECSP088603A (es) | 2008-08-29 |
TW200730512A (en) | 2007-08-16 |
US20080293742A1 (en) | 2008-11-27 |
BRPI0619602A2 (pt) | 2011-10-11 |
AR058319A1 (es) | 2008-01-30 |
NO20083070L (no) | 2008-08-28 |
RU2008122401A (ru) | 2010-01-20 |
UY29999A1 (es) | 2007-07-31 |
KR20080091139A (ko) | 2008-10-09 |
EP1968951B1 (de) | 2011-06-22 |
CL2006003449A1 (es) | 2008-02-08 |
EP1968951A1 (de) | 2008-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE513819T1 (de) | Neue n-(fluorpyrazinyl)phenylsulfonamide als modulatoren des chemokinrezeptors ccr4 | |
MA28580B1 (fr) | 3-(4-hétéroarylcyclohexylamino) cyclopentanecarboxamides servant de modulateurs de récepteurs de chimiokines | |
DK2060570T3 (da) | Som modulatorer af dopamin-d3-receptorer anvendelige azabicyclo(3.1.0)hexanderivater | |
ATE476424T1 (de) | Diazepanderivate als modulatoren von chemokinrezeptoren | |
ATE545631T1 (de) | N-(2-benzyl)-2-phenylbutanamide als androgenrezeptormodulatoren | |
ATE516274T1 (de) | Neue verbindungen als modulatoren des opioidrezeptors | |
DE602006010546D1 (de) | N-(pyridin-2-yl)sulfonamidderivate | |
ATE439357T1 (de) | Indolylderivate als liver-x-rezeptormodulatoren | |
DE60305903D1 (de) | Tropanderivative als ccr5-modulatoren | |
ATE533743T1 (de) | Harnstoffderivate von aminotetralin als modulatoren des vanilloid-rezeptors vr1 | |
ATE510831T1 (de) | Hydrierte benzoäcüthiophenderivate als immunmodulatoren | |
ATE549333T1 (de) | Neue sulfonylpyrrole als hdac-inhibitoren | |
DK1874914T3 (da) | Flydende detergentsammensætning | |
ATE487717T1 (de) | Imidazo- und triazolopyridine als inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1 | |
ATE416168T1 (de) | Modulatoren des vanilloidrezeptors | |
FI20055089A0 (fi) | Liikeratanosturi | |
ATE497953T1 (de) | Thiazolderivate als modulatoren des cannabinoidrezeptors | |
DE602005024107D1 (de) | Flüssigkristall wiedergabeanordnung | |
DE602005014646D1 (de) | Substituierte propenylpiperazinderivate als neue inhibitoren von histondeacetylase | |
ATE420949T1 (de) | Impfstoff der einen attenuierten pestivirus enthält | |
NL2000380A1 (nl) | 3-aminocyclopentaancarboxamiden als modulatoren van chemokine-receptoren. | |
DK2447252T3 (da) | Theramuteinmodulatorer | |
DE602005023145D1 (de) | Neue androgene | |
DE602004023529D1 (de) | Regelung der Güte (Q) von Filtern | |
ATE460162T1 (de) | Neue kristallformen von irinotecan-hydrochlorid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |